Enoxaparin versus tinzaparin in non-ST–segment elevation acute coronary syndromes: the EVET trial

This publication has 27 references indexed in Scilit:

• Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: One-year results of the essence study
  Journal of the American College of Cardiology, 2000
• Low molecular weight heparin in acute coronary syndrome: evidence for superior or equivalent efficacy compared with unfractionated heparin?
  Journal of the American College of Cardiology, 2000
• Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis
  The Lancet, 2000
• Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S. (FRAxiparine in Ischaemic Syndrome)
  Published by Oxford University Press (OUP) ,1999
• Comparison of two low-molecular-weight heparins for the prevention of postoperative venous thromboembolism after elective hip surgery
  Blood Coagulation & Fibrinolysis, 1998
• A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Acute Pulmonary Embolism
  New England Journal of Medicine, 1997
• A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
  New England Journal of Medicine, 1997
• New Data on the Pharmacology of Heparin and Low Molecular Weight Heparins
  Drugs, 1996
• Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia
  Journal of the American College of Cardiology, 1995
• Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
  New England Journal of Medicine, 1995